Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Consumer-Commitment At HPS

It’s often said that we don’t appreciate our health until we lose it. According to a recent American Census, Americans are visiting doctors in decreasing numbers, yet our health is not improving. The hassle of paperwork associated with medical appointments has become one deterrent for patients, as it can leave them feeling perplexed, irked, and…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

It’s often said that we don’t appreciate our health until we lose it. According to a recent American Census, Americans are visiting doctors in decreasing numbers, yet our health is not improving. The hassle of paperwork associated with medical appointments has become one deterrent for patients, as it can leave them feeling perplexed, irked, and swamped.

Even for those fortunate enough to have health insurance, visiting their physicians can feel daunting. Americans are busier than ever, working increasingly more hours, and yet they feel frustrated by the amount of financial responsibility involved in managing their health. Oftentimes, consumers even feel overwhelmed with high deductibles and powerless to navigate complex billing systems. A single medical procedure results in multiple bills from multiple providers, and a stack of EOBs from the insurance company to sift through. They often don’t understand what they are billed for, what is covered, what has been paid, and so on.

Since 2010, deductibles have risen by an astounding 44% for workers enrolled in a single coverage plan, and the number of those enrolled in high deductible plans continues to rise at an alarming rate. This translates to higher costs for consumers, an increase in medical collections activity, and amplified frustration and confusion for patients. It’s no wonder people are hesitant to go to the doctor.

Those at HPS are concerned for the health and well-being of your employees. They are dedicated to empowering patients by compiling and sorting all the data for your employees and creating a simple process with one statement, one payment, and one place to call.

HPS takes a consumer-centric approach, focusing on streamlining the medical insurance and billing process for patients. HPS was awarded the Health 2.0 Design for Health for consumer-centric healthcare solutions.

HPS takes a consumer-centric approach, focusing on streamlining the medical insurance and billing process for patients. HPS offers employees a program in which one monthly statement will be received after sorting through all the bills and EOBs to simplify the data. This allows patients to finance their health care over time by making one monthly payment to cover the owed balances. This system focuses on what is right for the consumer by alleviating multiple points of stress and confusion inherent in the current standard health care insurance and billing methods. HPS is proud to be the only organization to offer these services to consumers.

HPS has created a system centered on employee needs, and this claim has been validated by the market. In 2017, HPS was awarded the Health 2.0 Design for Health for consumer-centric healthcare solutions. In addition, HPS was recognized by Health and Human Services (HHS) for our Transformational Approach to healthcare billing. 12 Wisconsin Federal Congressional delegates signed a letter to HHS, endorsing the HPS solution and its value to the market in 2016. HIMSS, as a part of its Patient Financial Experience of the Future, has identified the need for a consolidated bill and EOB over a continuum of care to support the consumer. HPS offers that solution.

HPS makes the administration of healthcare more efficient, reduces administrative expenses, and gives consumers access to the health care they deserve, alleviating the confusion and frustration. Furthermore, this simple plan minimizes the generation of medical debt that adversely affects consumers and the market at large. HPS is committed to consumers, driving everything they do.

One statement, one payment, and one place to call.

To learn more about how HPS can make positive changes for you and your employees when it comes to health care, visit us online today!.

Read more at hps.md

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512